Empagliflozin Metformin Duo Tablet 5/850 mg
Empagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
MFDS item code 202201362 · Approved 2022.04.04
Improvement of glycemic control in adults with type 2 diabetes mellitus
This drug is used to improve glycemic control in adult patients with type 2 diabetes who are suitable for the combination use of empagliflozin and metformin. It helps manage blood sugar effectively when taken in conjunction with dietary and exercise regimens. It is particularly important to consult with a healthcare professional about the potential impact on cardiovascular events in adults with type 2 diabetes who do not achieve adequate blood sugar control and have existing cardiovascular conditions. This medication aids in the treatment of type 2 diabetes by improving blood sugar control.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined according to each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients taking this medicine who do not achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take twice the dose at one time; if this occurs, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual single-ingredient products of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered as this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Cautious Administration, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication helps control blood sugar levels. However, there is a risk of a serious condition known as lactic acidosis, so caution is required when using this medication. Particular care should be taken in conjunction with insulin or sulfonylurea medications, as hypoglycemia may occur. This drug should not be used in patients with moderate to severe renal impairment, acute renal status, type 1 diabetes, or acute or chronic metabolic acidosis. Additionally, use should be avoided or temporarily discontinued in situations such as acute myocardial infarction, heart failure, severe infections, and before or after surgery. While taking this medication, renal function should be regularly monitored for abnormalities, and if dehydration, severe vomiting, or diarrhea occurs, medication should be temporarily paused. Also, there may be a risk of hypoglycemia when used in combination with insulin or sulfonylureas, necessitating dosage adjustments. Common side effects include hypoglycemia, urinary tract infections, genital infections, and increased urination. Serious side effects such as liver function abnormalities, skin rashes, interstitial nephritis, and necrotizing fasciitis have been reported; if symptoms occur, consult a doctor immediately. Women who are pregnant or breastfeeding should not take this medication, and the elderly or those with poor nutritional status should use it more cautiously. This medication may interact with other drugs, so if you are taking other medications, be sure to inform your doctor or pharmacist. In the event of an overdose, serious side effects such as lactic acidosis may occur, so if an overdose is suspected, seek immediate medical care. Lastly, this medication should be kept out of reach of children and stored in its original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. Additionally, it is advisable to store the medication at room temperature, specifically between 1 to 30 degrees Celsius, avoiding places that are too hot or too cold.
Biconvex oval film-coated tablet that is white with a yellow tint
10 tablets/box [10 tablets/PTP x 1], 60 tablets/box [10 tablets/PTP x 6], 30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.